Search by Drug Name or NDC
NDC 00013-2596-91 Idamycin PFS 1 mg/mL Details
Idamycin PFS 1 mg/mL
Idamycin PFS is a INTRAVENOUS SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is IDARUBICIN HYDROCHLORIDE.
MedlinePlus Drug Summary
Idarubicin is used treat acute myelogenous leukemia (AML; a type of cancer of the white blood cells) in combination with other medications. Idarubicin is in a class of medications called anthracyclines. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00013-2596-91Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Idarubicin
Product Information
NDC | 00013-2596 |
---|---|
Product ID | 0013-2596_25de0c4d-09a1-45b6-b829-ea608205dd0b |
Associated GPIs | 21200045102035 |
GCN Sequence Number | 036763 |
GCN Sequence Number Description | idarubicin HCl VIAL 1 MG/ML INTRAVEN |
HIC3 | V1D |
HIC3 Description | ANTIBIOTIC ANTINEOPLASTICS |
GCN | 34248 |
HICL Sequence Number | 006024 |
HICL Sequence Number Description | IDARUBICIN HCL |
Brand/Generic | Brand |
Proprietary Name | Idamycin PFS |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | idarubicin hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1 |
Active Ingredient Units | mg/mL |
Substance Name | IDARUBICIN HYDROCHLORIDE |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Pharmaceutical Class | Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA050734 |
Listing Certified Through | 2025-12-31 |
Package
NDC 00013-2596-91 (00013259691)
NDC Package Code | 0013-2596-91 |
---|---|
Billing NDC | 00013259691 |
Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2596-91) / 20 mL in 1 VIAL, SINGLE-DOSE |
Marketing Start Date | 1997-02-17 |
NDC Exclude Flag | N |
Pricing Information | N/A |